Literature DB >> 7439263

Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration.

T Ishizaki, T Sasaki, T Suganuma, Y Horai, K Chiba, M Watanabe, W Asuke, H Hoshi.   

Abstract

The pharmacokinetics of ketoprofen was studied in the same healthy subjects after single oral, intramuscular and rectal doses, and after repeated oral administration. No significant difference in the mean t1/2 (1.13-1.27 h) was observed after the different modes of administration. The mean [AUC] 0 infinity after rectal administration of a suppository showed the minimum significant difference (p < 0.05) from that after oral administration of the capsule. The apparent volume of distribution (Vd/F) was approximately 10-15% of body weight. The renal contribution (mean, 0.10-0.15 ml/min/kg) to the plasma clearance of free ketoprofen was assumed to be, at most, 8.3-12.9%. The projected cumulative excretion of total (free plus conjugated) ketoprofen via urine exceeded 63-75% of the dose, of which approximately 90% was ketoprofen glucuronide. A mean of 71-96% and 73-93% of the oral capsule was estimated to be systemically available after administration of the intramuscular preparation and rectal suppository, respectively. In four of seven subjects, CPK concentration was elevated after the intramuscular injection. The mean steady-state concentration of ketoprofen in plasma ranged from 0.43 to 5.62 microgram/ml after the final dose of a 50 mg q. i. d. regimen. The disposition data and plasma levels observed at steady-state were in agreement with those predicted from the single oral dose study. The accumulation ratio was 1.08 +/- 0.08. The results suggest that the rectal suppository can be recommended as an extravascular mode of administration of this drug.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7439263     DOI: 10.1007/bf00636794

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  28 in total

Review 1.  Clinical pharmacokinetics (second of two parts).

Authors:  D J Greenblatt; J Koch-Weser
Journal:  N Engl J Med       Date:  1975-11-06       Impact factor: 91.245

2.  Evaluation of analgesic action and efficacy of antirheumatic drugs. Study of 10 drugs in 684 patients with rheumatoid arthritis.

Authors:  P Lee; J A Anderson; J Miller; J Webb; W W Buchanan
Journal:  J Rheumatol       Date:  1976-09       Impact factor: 4.666

Review 3.  Ketoprofen. A survey of current publications.

Authors:  J Fossgreen
Journal:  Scand J Rheumatol Suppl       Date:  1976

4.  Intramuscular injection of drugs.

Authors:  D J Greenblatt; J Koch-Weser
Journal:  N Engl J Med       Date:  1976-09-02       Impact factor: 91.245

5.  Serum creatine phosphokinase activity after intramuscular injection. The effect of dose, concentration, and volume.

Authors:  F R Sidell; D L Culver; A Kaminskis
Journal:  JAMA       Date:  1974-09-30       Impact factor: 56.272

6.  [Determination of (benzoyl-3 phenyl)-2 propionic acid or ketoprofen in biological media].

Authors:  P Populaire; B Terlain; S Pascal; B Decouvelaere; G Lebreton; A Renard; J P Thomas
Journal:  Ann Pharm Fr       Date:  1973-11

7.  An overview of the analysis and interpretation of bioavailability studies in man.

Authors:  J G Wagner
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

8.  Physiological disposition of fenoprofen in man. I. Pharmacokinetic comparison of calcium and sodium salts administered orally.

Authors:  A Rubin; B E Rodda; P Warrick; A Ridolfo; C M Gruber
Journal:  J Pharm Sci       Date:  1971-12       Impact factor: 3.534

9.  Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects.

Authors:  R Runkel; M Chaplin; G Boost; E Segre; E Forchielli
Journal:  J Pharm Sci       Date:  1972-05       Impact factor: 3.534

10.  Studies on 2-(3-benzoylphenyl) propionic acid (Orudis). A double-blind cross-over trial in patients with rheumatoid arthritis and an assessment of its influence on hepatic drug-metabolizing enzymes.

Authors:  B J Cathcart; J D Vince; A J Gordon; M A Bell; I M Chalmers
Journal:  Ann Rheum Dis       Date:  1973-01       Impact factor: 19.103

View more
  27 in total

1.  Percutaneous absorption of ketoprofen from different anatomical sites in man.

Authors:  A K Shah; G Wei; R C Lanman; V O Bhargava; S J Weir
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

Review 2.  Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.

Authors:  Imke H Bartelink; Carin M A Rademaker; Alfred F A M Schobben; John N van den Anker
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Circadian changes in the pharmacokinetics of oral ketoprofen.

Authors:  M Ollagnier; H Decousus; Y Cherrah; F Levi; M Mechkouri; P Queneau; A Reinberg
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

Review 4.  The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly.

Authors:  K W Woodhouse; H Wynne
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

5.  Diclofenac and ketoprofen liver toxicity in rat.

Authors:  Zdenko Tomic; Boris Milijasevic; Ana Sabo; Lalosevic Dusan; Vida Jakovljevic; Momir Mikov; Satman Majda; Velibor Vasovic
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

6.  Pharmacokinetics of intravenous and rectal ketoprofen in young children.

Authors:  Hannu Kokki; Marko Karvinen; Pekka Suhonen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 7.  Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

Review 8.  Rectal drug administration: clinical pharmacokinetic considerations.

Authors:  A G de Boer; F Moolenaar; L G de Leede; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

9.  The clinical pharmacokinetics of two different preparations of intrarectal ketoprofen following spinal or local anesthesia for anal surgery.

Authors:  K Tazawa; S Takemori; S Hirokawa; K Yamamoto; S Katsuki; H Arai; T Kasagi; S Katsuyama; M Fujimaki
Journal:  Jpn J Surg       Date:  1991-11

10.  Klucel™ EF and ELF polymers for immediate-release oral dosage forms prepared by melt extrusion technology.

Authors:  Noorullah Naqvi Mohammed; Soumyajit Majumdar; Abhilasha Singh; Weibin Deng; Narasimha S Murthy; Elanor Pinto; Divya Tewari; Thomas Durig; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2012-09-08       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.